Literature DB >> 12959396

Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?

Elias S Siraj1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12959396     DOI: 10.3949/ccjm.70.8.702

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  5 in total

1.  The impact of initiating biphasic human insulin 30 therapy in type 2 diabetes patients after failure of oral antidiabetes drugs.

Authors:  Yunjuan Gu; Xuhong Hou; Lei Zhang; Jiemin Pan; Qingxia Cai; Yuqian Bao; Weiping Jia
Journal:  Diabetes Technol Ther       Date:  2011-11-02       Impact factor: 6.118

2.  The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis.

Authors:  Ai-Qing Yu; Jiong Le; Wen-Tao Huang; Bin Li; Hui-Xin Liang; Qun Wang; Yu-Ting Liu; Charlotte-Aimee Young; Mei-Ying Zhang; Shu-Lan Qin
Journal:  Adv Ther       Date:  2021-01-09       Impact factor: 3.845

3.  Management of diabetes across the course of disease: minimizing obesity-associated complications.

Authors:  Caroline M Apovian
Journal:  Diabetes Metab Syndr Obes       Date:  2011-10-12       Impact factor: 3.168

4.  Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman.

Authors:  Akram Nakhaee; Mojgan Sanjari
Journal:  J Res Med Sci       Date:  2013-05       Impact factor: 1.852

5.  Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients.

Authors:  Sirajudeen Shaik Alavudeen; Moteb Khobrani; C K Dhanapal; Javid Iqbal Mir; Sultan Mohammed Alshahrani; Noohu Abdullah Khan; Abdulaziz Alhossan
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.